|
COLOWIDE CO., LTD. (7616.t) DCF -Bewertung
JP | Consumer Cyclical | Restaurants | JPX
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Colowide Co.,Ltd. (7616.T) Bundle
Übernehmen Sie die Ladung für Ihre Colowide Co., Ltd. (7616T) Bewertungsanalyse mit unserem ausgefeilten DCF -Taschenrechner! Diese Excel -Vorlage mit realen (7616T-) Daten wird vorinstalliert und ermöglicht es Ihnen, Vorhersagen und Annahmen für eine genaue Berechnung des intrinsischen Wertes von Colowide Co., Ltd., anzupassen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 235,334.0 | 168,181.0 | 175,627.0 | 220,830.0 | 241,284.0 | 247,854.5 | 254,604.0 | 261,537.2 | 268,659.2 | 275,975.2 |
| Revenue Growth, % | 0 | -28.54 | 4.43 | 25.74 | 9.26 | 2.72 | 2.72 | 2.72 | 2.72 | 2.72 |
| EBITDA | 20,151.0 | 11,849.0 | 28,509.0 | 17,118.0 | 32,118.0 | 26,224.9 | 26,939.0 | 27,672.6 | 28,426.2 | 29,200.3 |
| EBITDA, % | 8.56 | 7.05 | 16.23 | 7.75 | 13.31 | 10.58 | 10.58 | 10.58 | 10.58 | 10.58 |
| Depreciation | 25,950.0 | 22,777.0 | 21,765.0 | 22,696.0 | 22,788.0 | 28,099.2 | 28,864.4 | 29,650.4 | 30,457.8 | 31,287.2 |
| Depreciation, % | 11.03 | 13.54 | 12.39 | 10.28 | 9.44 | 11.34 | 11.34 | 11.34 | 11.34 | 11.34 |
| EBIT | -5,799.0 | -10,928.0 | 6,744.0 | -5,578.0 | 9,330.0 | -1,874.3 | -1,925.4 | -1,977.8 | -2,031.6 | -2,087.0 |
| EBIT, % | -2.46 | -6.5 | 3.84 | -2.53 | 3.87 | -0.75621 | -0.75621 | -0.75621 | -0.75621 | -0.75621 |
| Total Cash | 33,272.0 | 39,411.0 | 49,453.0 | 50,700.0 | 46,849.0 | 53,588.7 | 55,048.0 | 56,547.1 | 58,086.9 | 59,668.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 11,880.0 | 16,386.0 | 15,567.0 | 11,892.0 | 13,158.0 | 17,098.7 | 17,564.3 | 18,042.6 | 18,533.9 | 19,038.6 |
| Account Receivables, % | 5.05 | 9.74 | 8.86 | 5.39 | 5.45 | 6.9 | 6.9 | 6.9 | 6.9 | 6.9 |
| Inventories | 3,297.0 | 2,806.0 | 2,804.0 | 3,492.0 | 3,932.0 | 3,904.7 | 4,011.0 | 4,120.2 | 4,232.4 | 4,347.7 |
| Inventories, % | 1.4 | 1.67 | 1.6 | 1.58 | 1.63 | 1.58 | 1.58 | 1.58 | 1.58 | 1.58 |
| Accounts Payable | 23,748.0 | 15,374.0 | 17,533.0 | 23,661.0 | 23,999.0 | 24,724.3 | 25,397.5 | 26,089.2 | 26,799.6 | 27,529.4 |
| Accounts Payable, % | 10.09 | 9.14 | 9.98 | 10.71 | 9.95 | 9.98 | 9.98 | 9.98 | 9.98 | 9.98 |
| Capital Expenditure | -9,296.0 | -5,323.0 | -5,741.0 | -9,220.0 | -12,963.0 | -9,880.3 | -10,149.4 | -10,425.8 | -10,709.7 | -11,001.3 |
| Capital Expenditure, % | -3.95 | -3.17 | -3.27 | -4.18 | -5.37 | -3.99 | -3.99 | -3.99 | -3.99 | -3.99 |
| Tax Rate, % | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 | 55.29 |
| EBITAT | -4,229.7 | -7,893.3 | 4,725.1 | -4,491.6 | 4,171.1 | -1,276.3 | -1,311.0 | -1,346.7 | -1,383.4 | -1,421.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 20,995.3 | -2,828.3 | 23,729.1 | 18,099.4 | 12,628.1 | 13,754.5 | 17,505.3 | 17,982.0 | 18,471.7 | 18,974.7 |
| WACC, % | 4.02 | 4.01 | 3.96 | 4.18 | 3.44 | 3.92 | 3.92 | 3.92 | 3.92 | 3.92 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 76,962.3 | |||||||||
| Long Term Growth Rate, % | 3.30 | |||||||||
| Free cash flow (T + 1) | 19,601 | |||||||||
| Terminal Value | 3,161,146 | |||||||||
| Present Terminal Value | 2,608,241 | |||||||||
| Enterprise Value | 2,685,204 | |||||||||
| Net Debt | 108,898 | |||||||||
| Equity Value | 2,576,306 | |||||||||
| Diluted Shares Outstanding, MM | 87 | |||||||||
| Equity Value Per Share | 29,716.32 |
Benefits You Will Receive
- Authentic 7616T Financial Data: Pre-loaded with Colowide Co., Ltd.'s historical and projected figures for accurate analysis.
- Customizable Template: Easily adjust essential inputs such as revenue growth, WACC, and EBITDA percentage.
- Real-Time Calculations: Automatically update Colowide's intrinsic value based on your input modifications.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: Organized layout and straightforward instructions suitable for all skill levels.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Colowide Co., Ltd. (7616T).
- WACC Analyzer: Pre-structured Weighted Average Cost of Capital template with adjustable inputs for precise calculations.
- Customizable Forecast Parameters: Easily adjust growth rates, capital expenditures, and discount rates to meet your analysis needs.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Colowide Co., Ltd. (7616T).
- Interactive Dashboard and Graphs: Visual representations highlight key valuation metrics for straightforward interpretation.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Colowide Co., Ltd.'s pre-filled financial data and forecasts.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real time as you make changes to your assumptions.
- Step 5: Evaluate the results and utilize them for your investment decisions.
Why Choose This Calculator for Colowide Co., Ltd. (7616T)?
- Precise Data: Up-to-date Colowide financials guarantee dependable valuation outcomes.
- Flexible Settings: Tailor key metrics such as growth projections, WACC, and tax rates to suit your analysis.
- Efficiency Boost: Ready-to-use calculations save you from starting anew.
- Professional-Quality Tool: Crafted for investors, analysts, and consultants specializing in Colowide.
- User-Friendly Interface: Intuitive design and guided steps ensure accessibility for all users.
Who Should Utilize Colowide Co., Ltd. (7616T)?
- Investors: Evaluate Colowide's market value before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation workflows and assess future projections.
- Startup Founders: Gain insights into how established firms like Colowide are valued.
- Consultants: Provide expert valuation assessments for clients involving Colowide.
- Students and Educators: Utilize real market data to practice and teach valuation methods.
Contents of the Template
- Operating and Balance Sheet Data: Pre-filled historical data and forecasts for Colowide Co., Ltd. (7616T), including metrics such as revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A specific sheet for calculating the Weighted Average Cost of Capital (WACC), detailing parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Customizable Discounted Cash Flow models that illustrate intrinsic value alongside comprehensive calculations.
- Financial Statements: Pre-loaded annual and quarterly financial statements for thorough analysis.
- Key Ratios: A set of profitability, leverage, and efficiency ratios relevant to Colowide Co., Ltd. (7616T).
- Dashboard and Charts: A visual overview of valuation outputs and underlying assumptions to facilitate quick analysis of results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.